Požymis
Bulge in wall of large artery that carries blood away from heart
Klinikinis pavadinimas: Aortic aneurysm
Aortic dilatation refers to a dimension that is greater than the 95th percentile for the normal person age, sex and body size. In contrast, an aneurysm is defined as a localized dilation of the aorta that is more than 150 percent of predicted (ratio of observed to expected diameter 1.5 or more). Aneurysm should be distinguished from ectasia, which represents a diffuse dilation of the aorta less than 50 percent of normal aorta diameter.
Santrauka
- Taip pat vadinama
- Enlarged aorta
- Kūno sistema
- Abnormality of the cardiovascular system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Bulge in wall of large artery that carries blood away from heart, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test66 genų susiję su Bulge in wall of large artery that carries blood away from heart
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Bulge in wall of large artery that carries blood away from heart. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| FBN1fibrillin 1 | Visada | 1 ligoje |
| POLR1ARNA polymerase I subunit A | Visada | 1 ligoje |
| TAF4TATA-box binding protein associated factor 4 | Visada | 1 ligoje |
| TNNT2troponin T2, cardiac type | Visada | 1 ligoje |
| IPO8importin 8 | Labai dažnai (80–99%) | 1 ligoje |
| SLC2A10solute carrier family 2 member 10 | Labai dažnai (80–99%) | 1 ligoje |
| SMAD2SMAD family member 2 | Labai dažnai (80–99%) | 1 ligoje |
| SMAD3SMAD family member 3 | Labai dažnai (80–99%) | 2 ligose |
| TGFB2transforming growth factor beta 2 | Labai dažnai (80–99%) | 1 ligoje |
| TGFB3transforming growth factor beta 3 | Labai dažnai (80–99%) | 1 ligoje |
| TGFBR1transforming growth factor beta receptor 1 | Labai dažnai (80–99%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Labai dažnai (80–99%) | 1 ligoje |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Dažnai (30–79%) | 1 ligoje |
| DPH5diphthamide biosynthesis 5 | Dažnai (30–79%) | 1 ligoje |
| ELNelastin | Dažnai (30–79%) | 1 ligoje |
| FBLN5fibulin 5 | Dažnai (30–79%) | 1 ligoje |
| NOTCH3notch receptor 3 | Dažnai (30–79%) | 1 ligoje |
| RIN2Ras and Rab interactor 2 | Dažnai (30–79%) | 2 ligose |
| SLC25A24solute carrier family 25 member 24 | Dažnai (30–79%) | 1 ligoje |
| TAB2TGF-beta activated kinase 1 (MAP3K7) binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| APC2APC regulator of Wnt signaling pathway 2 | Kartais (5–29%) | 1 ligoje |
| ARF1ARF GTPase 1 | Kartais (5–29%) | 1 ligoje |
| ARFGEF2ARF guanine nucleotide exchange factor 2 | Kartais (5–29%) | 1 ligoje |
| BCRBCR activator of RhoGEF and GTPase | Kartais (5–29%) | 1 ligoje |
| CHRNGcholinergic receptor nicotinic gamma subunit | Kartais (5–29%) | 1 ligoje |
| COL3A1collagen type III alpha 1 chain | Kartais (5–29%) | 1 ligoje |
| CRKLCRK like proto-oncogene, adaptor protein | Kartais (5–29%) | 1 ligoje |
| ERMARDER membrane associated RNA degradation | Kartais (5–29%) | 1 ligoje |
| FBN2fibrillin 2 | Kartais (5–29%) | 1 ligoje |
| FBXO11F-box protein 11 | Kartais (5–29%) | 1 ligoje |
| FLNAfilamin A | Kartais (5–29%) | 1 ligoje |
| HGDhomogentisate 1,2-dioxygenase | Kartais (5–29%) | 2 ligose |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Kartais (5–29%) | 2 ligose |
| MAP1Bmicrotubule associated protein 1B | Kartais (5–29%) | 1 ligoje |
| MAPK1mitogen-activated protein kinase 1 | Kartais (5–29%) | 1 ligoje |
| MED12mediator complex subunit 12 | Kartais (5–29%) | 1 ligoje |
| MYH3myosin heavy chain 3 | Kartais (5–29%) | 1 ligoje |
| NEDD4LNEDD4 like E3 ubiquitin protein ligase | Kartais (5–29%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Kartais (5–29%) | 1 ligoje |
| NSD1nuclear receptor binding SET domain protein 1 | Kartais (5–29%) | 1 ligoje |
Rodyti dar 26 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| PLOD1procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Kartais (5–29%) | 1 ligoje |
| PTENphosphatase and tensin homolog | Kartais (5–29%) | 1 ligoje |
| RAI1retinoic acid induced 1 | Kartais (5–29%) | 1 ligoje |
| SKISKI proto-oncogene | Kartais (5–29%) | 1 ligoje |
| SMAD6SMAD family member 6 | Kartais (5–29%) | 1 ligoje |
| TMTC3transmembrane O-mannosyltransferase targeting cadherins 3 | Kartais (5–29%) | 1 ligoje |
| TNXBtenascin XB | Kartais (5–29%) | 1 ligoje |
| ADARadenosine deaminase RNA specific | Retai (1–4 %) | 1 ligoje |
| IFIH1interferon induced with helicase C domain 1 | Retai (1–4 %) | 1 ligoje |
| IFNGinterferon gamma | Retai (1–4 %) | 1 ligoje |
| LSM11LSM11, U7 small nuclear RNA associated | Retai (1–4 %) | 1 ligoje |
| RNASEH2Aribonuclease H2 subunit A | Retai (1–4 %) | 1 ligoje |
| RNASEH2Bribonuclease H2 subunit B | Retai (1–4 %) | 1 ligoje |
| RNASEH2Cribonuclease H2 subunit C | Retai (1–4 %) | 1 ligoje |
| RNU7-1RNA, U7 small nuclear 1 | Retai (1–4 %) | 1 ligoje |
| SAMHD1SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | Retai (1–4 %) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Retai (1–4 %) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Retai (1–4 %) | 1 ligoje |
| TSC1TSC complex subunit 1 | Retai (1–4 %) | 1 ligoje |
| TSC2TSC complex subunit 2 | Retai (1–4 %) | 1 ligoje |
| ACTA2actin alpha 2, smooth muscle | Neužfiksuota | 1 ligoje |
| C12orf57chromosome 12 open reading frame 57 | Neužfiksuota | 1 ligoje |
| COL1A1collagen type I alpha 1 chain | Neužfiksuota | 1 ligoje |
| FLNBfilamin B | Neužfiksuota | 1 ligoje |
| FOXE3forkhead box E3 | Neužfiksuota | 1 ligoje |
| MYLKmyosin light chain kinase | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites